Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19

Technology appraisal guidance
Reference number: TA878
Published: 29 March 2023
Last updated: 13 March 2024

An appeal has been lodged for this appraisal, however it was rejected. Below are the papers related to the appeal.

Cardiothoracic Transplant Patient Group : Appeal letter (MSWord 28 KB)

Published:

13 March 2024
NICE : Scrutiny letter (MSWord 89 KB)

Published:

13 March 2024
Cardiothoracic Transplant Patient Group : Response to scrutiny letter (MSWord 30 KB)

Published:

13 March 2024
NICE : Final scrutiny letter (MSWord 77 KB)

Published:

13 March 2024

This page was last updated: 13 March 2024